Meggle Receives EXCiPACT Certification

Sep 04, 2014
By PharmTech Editors

Meggle Group Wasserburg announced that it has been granted an EXCiPACT certificate. Following an inspection on the company’s manufacturing processes, quality systems, quality management, storage and distribution of pharmaceutical grade lactose, and its associated auxiliary materials used in the production process, auditors from the certifying body SGS (Société Générale de Surveillance, Hamburg, Germany) have confirmed that the Meggle Business Group Excipients & Technology complies with the quality standards of good manufacturing and good distribution practices (GMP & GDP) for its pharmaceutical excipients.

The EXCiPACT certification assures optimal product quality and security within the supply chain as a means to protect patient safety and ensure efficient cost. Since its introduction in 2013, the EXCiPACT certificate has been granted only to a dozen companies. The certificate documents the high standard to which Meggle has committed. For many years, the company has operated according to the international industrial GMP/GDP standard and ISO norms.

The quality standards as defined in EXCiPACT are specifically for manufacturing and supply of pharmaceutical excipients. To ensure compliance with the standards, and consequently for the patient safety, the certificate holders are reviewed annually and re-audited every three years.

Source: Meggle